Substance use disorders and cancer are scientifically linked. Understanding the addiction-cancer connection means looking at both directions of risk. First, it involves how alcohol, opiates, illicit drugs and anabolic steroids increase cancer risk. Second, it considers how cancer treatment, especially pain management, can increase the risk of opioid dependence or relapse. Learn more about this connection and discover clear steps to reduce risk and seek help.
Each substance acts differently, but many share core pathways that raise cancer risk. The common thread is exposure to carcinogens and biological changes that make it easier for abnormal cells to grow and harder for the immune system to stop them.
Key mechanisms that drive addiction cancer risk include:
Different substances can cause cancer in different ways, and the proof is stronger for some than others. Discover known links, where the risks are strongest and how they show up in real-world use.
The connection between alcohol use and cancer is well-established. The body metabolizes ethanol into acetaldehyde, a carcinogen that can cause DNA damage and interfere with repair processes. Heavy drinking also drives oxidative stress and chronic inflammation. Oxidative stress is an imbalance of free radicals and antioxidants in the body that can lead to cell and tissue damage and contribute to the development of chronic conditions like cancer, diabetes and heart disease.
Alcohol can also raise estrogen levels, which may affect breast tissue and increase the chance of developing breast and ovarian cancer. In fact, research suggests that cutting out alcohol is one of the best ways to lower your risk, especially if cancer runs in your family or you have a known genetic predisposition.
In the liver, long-term heavy alcohol use often follows a predictable disease pathway:
Cirrhosis sharply increases the risk of hepatocellular carcinoma, the most common type of liver cancer.
Quitting drinking by seeking treatment for alcohol dependence can lower your cancer risk. Research suggests that the longer you stay alcohol‑free, the more your risk drops. In one study, cancer risk was about one-third lower after 10 to 19 years of not drinking, and about half as high after more than 20 years.
Opioids themselves aren't classified as carcinogens, but opioid use and opioid dependence can increase cancer risk indirectly. These are the key ways opioids intersect with cancer risk:
For illicit drugs, cancer risk often stems from a combination of the drug's effects, the way it's administered and contaminants.
Street supplies of heroin, fentanyl, meth and counterfeit benzodiazepines are often cut with chemicals to stretch the product or change its effects. Some adulterants have known cancer links. For example, Phenacetin has been tied to cancers of the kidney's collecting system, while others are unknown. Because users can't be sure what's in a cutting agent, each use may quietly add risk over time.
In addition, people who use nonmedical opium-derived drugs like heroin have a much higher risk of cancer — about four times higher than nonusers, even after accounting for other factors like age or smoking.
Behavioral patterns that are common in illicit drug use can also weaken the body's defenses. Meth-related sleep loss, poor nutrition during opioid dependence and coinfections like human immunodeficiency virus or human papillomavirus strain the immune system and make it harder to find and destroy early cancer cells.
Many of these risks are preventable with evidence-based treatment to stop use, which is why it's important to access treatment as soon as possible. Medically supervised detox and integrated adult programs offer a safe, effective path to recovery and may lower long-term cancer risk.
Using anabolic steroids without a prescription over a long time can put serious strain on your liver and affect hormone‑driven organs like the prostate. The clearest danger is liver tumors, and there may be prostate risks, too.
Here's what research shows about steroids and cancer risk:
A cancer diagnosis and treatment can be triggers for new or recurrent substance use. Pain, anxiety, insomnia, nausea and emotional distress are common, and many cancer care pathways rely on medications with dependence potential.
Opioids are an often necessary part of cancer pain relief. However, tolerance and physical dependence can develop quickly, and some patients struggle with opioid addiction after treatment ends. Balancing relief and risk is possible.
Opioids for pain, benzodiazepines for anxiety and nausea, and corticosteroids for swelling are often essential during cancer treatment, but they can also create dependence risks, making it harder to cut back after treatment ends.
Benzodiazepines may help with procedures or severe anxiety, but can worsen sleep and memory over time, and are hard to stop without a plan. Corticosteroids can trigger mood changes, insomnia and agitation that drive more medication use. When these drugs are combined or continued for months, the odds of persistent use and misuse rise, especially without close monitoring and a tapering strategy.
Studies show that about 21% to 29% of people using opioids for long-term pain take the medication in ways not prescribed by their doctor. This is also known as drug misuse.
Cancer brings intense stressors that can fuel cravings or relapse. Sleep disruption, isolation from normal routines and financial worries all chip away at a person's coping capacity. People with a history of substance use are especially vulnerable when stress peaks around diagnosis, surgery or scan results. Without emotional support and practical tools, it's easy to lean more on sedating medications or alcohol, which increases the risk of dependence.
Cancer care often involves many medications at once. They can interact, increasing sedation and making it harder to tell which drug is helping or harming. Longer treatment timelines, frequent dose changes and multiple prescribers can lead to using more medications than intended or overlapping prescriptions. Hospital-to-home transitions are another weak spot where refills may be continued automatically.
All of this raises exposure to dependence-forming medications unless a single clinician coordinates the plan and reassesses regularly.
Many patients don't have a team that treats cancer and addiction together, so they're left to navigate mixed messages and competing priorities on their own. Screening for substance use risk is inconsistent, and many clinics lack clear pathways for medication-assisted treatment during active cancer care. Stigma and insurance barriers can also delay help.
A national survey of cancer survivors found that about 1 in 25 respondents had an active substance use disorder in the past year. Rates were higher, about 1 in 11, among survivors of head and neck cancers and esophageal or stomach cancers. Alcohol use disorder was the most common.
These results suggest certain groups of cancer survivors would benefit from routine screening and integrated addiction support as part of their cancer care. When oncology, pain management and addiction specialists collaborate, patients get safer pain control and earlier support.
No matter where you're starting, you can take steps to lower risk and support recovery. Progress builds over time, and small changes today can lead to significant health benefits, including a reduced risk of cancer.
Some actionable tips for people using substances and concerned about cancer include:
If you're a patient worried about cancer pain management addiction, you should:
At Diamond House Detox, our whole‑person approach addresses mind, body and spirit with evidence‑based care designed for clients with co‑occurring disorders and underlying mental health symptoms. Unlike programs that focus only on substance use, we prioritize physical, emotional and psychological recovery. We believe that truly understanding each individual leads to better outcomes throughout detox and rehabilitation.
Our inpatient rehab features an advanced, six‑bed facility in beautiful Elk Grove, created to support healing. With years of innovative experience, our medical professionals deliver holistic treatment that integrates therapy, medication-assisted options when appropriate and prescriptions tailored to each person's needs.
What sets us apart is how we treat and what we treat. We specialize in personalized care for substance use alongside often‑overlooked mental health conditions. By addressing every facet of addiction, not just the symptoms, we help clients build a sustainable foundation for long‑term recovery.
If you're ready to lower your cancer risk by addressing substance use disorder, or treat dependence caused by pain treatment, help is available. At Diamond House Detox, we support adults with medically supervised detox and comprehensive addiction treatment of various lengths.
Understanding the addiction-cancer connection is an important first step — now, take the next. Learn how to get started with our admissions process, verify your insurance benefits, and explore the safest, most effective path forward. We provide accessible, confidential care from a compassionate team committed to your long-term health.
Contact us today to start your journey toward recovery.
